Paving the way to improve therapy for Myeloproliferative Neoplasms

Long-acting IFNα induces durable molecular responses in myeloproliferative neoplasms. Emerging studies, including Saleiro et al. recently published in Nature Communications, have identified promising candidates that may synergise with IFNα by targeting stem cell function or feedback loops that media...

Descripción completa

Detalles Bibliográficos
Autores principales: Bywater, Megan, Lane, Steven W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418146/
https://www.ncbi.nlm.nih.gov/pubmed/36028499
http://dx.doi.org/10.1038/s41467-022-32694-2
_version_ 1784776883718586368
author Bywater, Megan
Lane, Steven W.
author_facet Bywater, Megan
Lane, Steven W.
author_sort Bywater, Megan
collection PubMed
description Long-acting IFNα induces durable molecular responses in myeloproliferative neoplasms. Emerging studies, including Saleiro et al. recently published in Nature Communications, have identified promising candidates that may synergise with IFNα by targeting stem cell function or feedback loops that mediate treatment resistance.
format Online
Article
Text
id pubmed-9418146
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-94181462022-08-28 Paving the way to improve therapy for Myeloproliferative Neoplasms Bywater, Megan Lane, Steven W. Nat Commun Comment Long-acting IFNα induces durable molecular responses in myeloproliferative neoplasms. Emerging studies, including Saleiro et al. recently published in Nature Communications, have identified promising candidates that may synergise with IFNα by targeting stem cell function or feedback loops that mediate treatment resistance. Nature Publishing Group UK 2022-08-26 /pmc/articles/PMC9418146/ /pubmed/36028499 http://dx.doi.org/10.1038/s41467-022-32694-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Comment
Bywater, Megan
Lane, Steven W.
Paving the way to improve therapy for Myeloproliferative Neoplasms
title Paving the way to improve therapy for Myeloproliferative Neoplasms
title_full Paving the way to improve therapy for Myeloproliferative Neoplasms
title_fullStr Paving the way to improve therapy for Myeloproliferative Neoplasms
title_full_unstemmed Paving the way to improve therapy for Myeloproliferative Neoplasms
title_short Paving the way to improve therapy for Myeloproliferative Neoplasms
title_sort paving the way to improve therapy for myeloproliferative neoplasms
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418146/
https://www.ncbi.nlm.nih.gov/pubmed/36028499
http://dx.doi.org/10.1038/s41467-022-32694-2
work_keys_str_mv AT bywatermegan pavingthewaytoimprovetherapyformyeloproliferativeneoplasms
AT lanestevenw pavingthewaytoimprovetherapyformyeloproliferativeneoplasms

Ejemplares similares